UnitedHealth Group (NYSE:UNH) Releases FY 2026 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 17.750- for the period, compared to the consensus estimate of 17.700. The company issued revenue guidance of $439.0 billion-, compared to the consensus revenue estimate of $456.6 billion.

UnitedHealth Group Trading Down 1.1%

UnitedHealth Group stock opened at $352.32 on Tuesday. UnitedHealth Group has a 1 year low of $234.60 and a 1 year high of $606.36. The company has a market cap of $319.15 billion, a P/E ratio of 18.39, a PEG ratio of 2.15 and a beta of 0.42. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. The firm’s 50-day moving average is $332.71 and its 200-day moving average is $323.96.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter in the previous year, the company posted $7.15 earnings per share. The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on UNH shares. Mizuho lifted their price target on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. The Goldman Sachs Group assumed coverage on shares of UnitedHealth Group in a research report on Tuesday, October 14th. They set a “buy” rating and a $406.00 price objective on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of UnitedHealth Group in a research report on Wednesday, January 21st. Royal Bank Of Canada boosted their price target on UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Finally, Piper Sandler cut their price objective on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research report on Tuesday, October 28th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $386.33.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth forecast 2026 adjusted profit slightly above analysts’ estimates, signaling that initial cost-control measures may be working. Read More.
• Positive Sentiment: Analysts note UnitedHealth’s decision to rebate ACA profits and other moves as strategically positive for reputation and competitive positioning. Read More.
• Neutral Sentiment: UnitedHealth posted a modest Q4 earnings beat and 12% consolidated revenue growth for 2025, showing operational resilience even as margins are pressured. Read More.
• Neutral Sentiment: The company reiterated its turnaround progress in its press release while providing updated full-year outlook metrics. Read More.
• Negative Sentiment: UnitedHealth took a $1.6 billion restructuring charge that pushed Q4 profit down to about $10 million — a large one-time hit that clouds near-term earnings. Read More.
• Negative Sentiment: The company issued weaker 2026 revenue guidance (around $439B vs. street ~$456.6B), signaling expected revenue decline and slower top-line growth next year — the main driver of today’s negative reaction. Read More.
• Negative Sentiment: Regulatory/policy headwinds: the Trump administration proposed nearly flat Medicare Advantage rates for 2026, removing a key tailwind for UnitedHealthcare and prompting sector-wide selling. Read More.
• Negative Sentiment: Market reaction and trading scrutiny: shares plunged on the news and a recent trade filing by a congressman has drawn attention, adding short-term negative sentiment and volatility risk. Read More.

Institutional Trading of UnitedHealth Group

Several hedge funds have recently added to or reduced their stakes in UNH. Northern Trust Corp grew its stake in UnitedHealth Group by 1.6% in the third quarter. Northern Trust Corp now owns 9,109,692 shares of the healthcare conglomerate’s stock valued at $3,145,577,000 after purchasing an additional 144,109 shares in the last quarter. Boston Partners grew its position in shares of UnitedHealth Group by 26.0% in the 3rd quarter. Boston Partners now owns 1,937,191 shares of the healthcare conglomerate’s stock valued at $671,169,000 after acquiring an additional 399,985 shares during the period. Lone Pine Capital LLC bought a new stake in UnitedHealth Group in the second quarter valued at approximately $528,273,000. Sustainable Growth Advisers LP increased its holdings in shares of UnitedHealth Group by 17.8% during the third quarter. Sustainable Growth Advisers LP now owns 1,640,012 shares of the healthcare conglomerate’s stock worth $566,296,000 after purchasing an additional 247,866 shares during the period. Finally, CANADA LIFE ASSURANCE Co grew its holdings in shares of UnitedHealth Group by 27.4% during the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 1,515,018 shares of the healthcare conglomerate’s stock worth $522,543,000 after purchasing an additional 325,476 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.